Pharmacological Treatment for Substance Use Disorders
Introduction
Substance use disorder treatment seeks to help the addicted people stop compulsive drug seeking and drug abuse behavior. Enna, (2018) defines pharmacology as a branch of medicine that deals with the uses, effects, and mode of action of substance into the body. Pharmacological treatment, therefore, is concerned with the making and consumption of drugs, and particularly the effects of drugs on the body. According to (Waldman & Terzic, 2018), pharmacological therapy involves the use of a single or multiple medicines depending with the type of client. Also, (Waldman & Terzic, 2018) defines substance use disorder as a relapsing disease whose brain damaging effect may be long term. In (Felman, 2018) pharmacology studies, this therapy helps addicts to recover sobriety and their consciousness, stop alcohol abuse, become more responsible in the society, work, and family, and in staying away from drug abuse/ use. Our paper aims to study the role of pharmacological treatment for substance use disorders.
Brief History of the Drug
Stating when the 1st pharmacological treatment of substance use disorders was put into practice is difficult. However, pharmacology originated in the 19th century and since then the process of drug development has been made possible thanks to Oswald, Abel, and Rudolf. The professors were psychologists whose set of experiments sought to study the effects of plants on animals. However, pharmacology turned an official study in the year 1847 (Waldman & Terzic, 2018). In the late 20th century and early the 21st centuries, the field of pharmacology attracted more interest by psychologists and other medical researchers. In this period, the pharmacological scientists, scholars, and researchers begun to study the structures and compounds of pharmacological drugs as far as body compatibility was concerned (Enna, 2018). Over the past five decades (50 years), alcohol use disorder remains the major cause for schizophrenia, stress, depression, and bipolar whose effects are very relapsing.
According to (Enna, 2018), clinical pharmacology, pharmacodynamics, and pharmacokinetics were developed before the end of 21st century. In the Second World War, further research on pharmacological treatment for substance use disorders was done in the U.S. by the American Medical Researchers in collaboration with the FDA. The need for therapy and substance use disorder treatment has been there since the beginning of 19th century….Continue Reading….